What is the role for idelalisib and duvelisib in CLL?
Promising CLL & FL data from ICML 2017: BGB-3111 and obinituzumab
Key questions to be discussed at iwCLL 2017: cancer genetics, immunology and categorizing patients
Improving the Cancer Journey: update and the role of pharmacists
What we can learn about treating CLL from research on other cancers